Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

NCT01101035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6198

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: Febuxostat
DRUG: Allopurinol

Sponsor

Takeda